About Rockwell Medical Inc
Ticker
info
RMTI
Trading on
info
NASDAQ
ISIN
info
US7743743004
Industry
info
Drug Manufacturers - Specialty & Generic
Sector
info
Healthcare
CEO
info
Dr. Mark Strobeck Ph.D.
Headquarters
info
30142 South Wixom road, Wixom, MI, United States, 48393
Employees
info
244
Website
info
rockwellmed.com
Rockwell Medical, Inc., together with its subsidiaries, develops, manufactures, commercializes, and distributes various hemodialysis products for dialysis providers worldwide. The company offers citrapure citric acid concentrate, dri-sate dry acid concentrate, renalpure liquid acid concentrate, dri-sate acid concentrate mixer, renalpure acid concentrate, renalpure bicarbonate concentrate, sterilyte bicarbonate concentrate, centrisol and renasol hemodialysis concentrates, and dry acid concentrate mixer, as well as ancillary products, including 5% acetic acid, cleaner, citric acid descaler, water softener salt pellets, and other supplies used by hemodialysis providers. Its hemodialysis concentrate products are used to sustain patient's life by removing toxins and balancing electrolytes in a dialysis patient's bloodstream. The company serves to hemodialysis clinics, including dialysis concentrates, dialysis kits, and other ancillary products used in the dialysis process. Rockwell Medical, Inc. was formerly known as Rockwell Medical Technologies, Inc. and changed its name to Rockwell Medical, Inc. in June 2012. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.
Metrics
BasicAdvanced
Market cap
info
$39.4M
P/E ratio
info
-
EPS
info
-$0.18
Dividend Yield
info
0.00%
Beta
info
1.62
Forward P/E ratio
info
59.17
EBIDTA
info
$-2.6M
Ex dividend date
info
-
Price & volume
Market cap
info
$39.4M
Average daily volume
info
0.3M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0
Forward P/E
info
59.17
PEG ratio
info
-0.79
Trailing P/E
info
0
Price to sales
info
0.52
Price to book
info
1
Earnings
EPS
info
-$0.18
EPS estimate (current quarter)
info
-$0.05
EPS estimate (next quarter)
info
-$0.05
EBITDA
info
$-2.6M
Revenues (TTM)
info
$75.6M
Revenues per share (TTM)
info
$2.20
Technicals
Beta
info
1.62
52-week High
info
$2.41
52-week Low
info
$0.78
50-day moving average
info
$1.09
200-day moving average
info
$1.18
Short ratio
info
2.14
Short %
info
2.68%
Management effectiveness
ROE (TTM)
info
-16.68%
ROA (TTM)
info
-5.25%
Profit margin
info
-7.30%
Gross profit margin
info
$11.4M
Operating margin
info
-9.95%
Growth
Quarterly earnings growth (YoY)
info
0.00%
Quarterly revenue growth (YoY)
info
-43.80%
Share stats
Outstanding Shares
info
39.4M
Float
info
35.2M
Insiders %
info
12.41%
Institutions %
info
8.57%
Analyst Insights & forecasts
info

100% Buy

0% Hold

0% Sell

Based on information from 2 analysts.

Average price target

info
$3.75
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
-$0.02
$0.02
-200.00%
Q4 • 24Missed
-$0.06
-$0.05
-20.00%
Q1 • 25Missed
-$0.01
-$0.05
80.00%
Q2 • 25Beat
-$0.05
-$0.05
-
Q3 • 25Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$16.1M
$-1.5M
-9.28%
Q2 • 25
$15.9M
$-1.8M
-11.01%
Q3 • 25
-0.90%
17.49%
18.56%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$52.6M
$22.2M
42.22%
Q2 • 25
$57.5M
$20.5M
35.60%
Q3 • 25
9.24%
-7.88%
-15.67%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$1.8M
$-0.1M
$-0.7M
$1.7M
Q2 • 25
$-1.3M
$-4.3M
$6.7M
$-1.5M
Q3 • 25
-170.88%
4,083.50%
-1,137.54%
-191.43%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Rockwell Medical Inc share?
Collapse

Rockwell Medical Inc shares are currently traded for undefined per share.

How many shares does Rockwell Medical Inc have?
Collapse

Rockwell Medical Inc currently has 39.4M shares.

Does Rockwell Medical Inc pay dividends?
Collapse

No, Rockwell Medical Inc doesn't pay dividends.

What is Rockwell Medical Inc 52 week high?
Collapse

Rockwell Medical Inc 52 week high is $2.41.

What is Rockwell Medical Inc 52 week low?
Collapse

Rockwell Medical Inc 52 week low is $0.78.

What is the 200-day moving average of Rockwell Medical Inc?
Collapse

Rockwell Medical Inc 200-day moving average is $1.18.

Who is Rockwell Medical Inc CEO?
Collapse

The CEO of Rockwell Medical Inc is Dr. Mark Strobeck Ph.D..

How many employees Rockwell Medical Inc has?
Collapse

Rockwell Medical Inc has 244 employees.

What is the market cap of Rockwell Medical Inc?
Collapse

The market cap of Rockwell Medical Inc is $39.4M.

What is the P/E of Rockwell Medical Inc?
Collapse

The current P/E of Rockwell Medical Inc is null.

What is the EPS of Rockwell Medical Inc?
Collapse

The EPS of Rockwell Medical Inc is -$0.18.

What is the PEG Ratio of Rockwell Medical Inc?
Collapse

The PEG Ratio of Rockwell Medical Inc is -0.79.

What do analysts say about Rockwell Medical Inc?
Collapse

According to the analysts Rockwell Medical Inc is considered a buy.